Searched for
SYMBIOTEC PHARMALAB IPO LISTING
Skyways Air shares to debut today; GMP signals 23% listing gainsThe IPO, which opened for subscription on August 24 and closed on August 27, drew a massive response across investor categories. The issue ...- Symbiotec Pharmalab shares to list today; GMP signals 19% listing gainThe Symbiotec Pharmalab IPO plans to channel Rs 112.50 crore towards the prepayment and/or repayment, fully or partially, of select outstan...
- Tempsens Instruments shares slide over 4% on profit booking after record listingTempsens Instruments shares fell over 4% on Monday as investors booked profits after the stock’s blockbuster debut on Friday. The shares ha...
- Augmont Enterprises shares debut at 22% premium over IPO priceThe Rs 825 crore IPO, priced at Rs 788 per share, comprised a fresh issue of 79 lakh shares worth Rs 620 crore and an offer for sale (OFS) ...
- IPO rush continues: 7 issues to raise over Rs 1,400 crore this weekThis week, investors can look forward to three mainboard initials and four SME IPOs, with a combined goal of raising over ₹1,400 crore in t...
- IPO fever grips D-Street: 3 issues to open for subscription; 8 new listings lined up for next weekIndia’s primary market is set for a busy week, with three mainboard IPOs opening to raise a combined Rs 1,264.72 crore. Meanwhile, eight co...
- 15 mainboard IPOs doubled investor money on listing day in last 6 years. See full listTempsens Instruments has ended a 609-day drought for mainboard IPOs doubling on debut. Here is the full list of 15 IPOs that delivered list...
- IPO investors waited 609 days for a stock to double on debut. Tempsens Instruments ends the droughtTempsens Instruments ended a 609-day drought in India’s mainboard IPO market, delivering a 111.3% listing gain on debut. The Rs 650 crore i...
- Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31xSymbiotec Pharmalab's IPO saw strong investor demand, closing oversubscribed 71.26 times. The company aimed to raise Rs 1,757 crore through...
- Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe?Symbiotec Pharmalab's IPO saw robust investor demand, with the issue subscribed 1.85 times. The company aims to raise Rs 1,757 crore throug...
- Strong Returns! IPO market heats up with 25% average listing gains in two monthsIndia’s IPO market has staged a strong comeback in July-August, with 18 of 22 listings delivering positive debut-day returns. Average listi...
- Symbiotec Pharmalab’s Rs 1,757 crore IPO opens with GMP hinting at 41% upside. Should you bid?Symbiotec Pharmalab IPO GMP: Symbiotec Pharmalab’s Rs 1,757 crore IPO opened August 24, with a Rs 938–988 price band and 41% grey-market pr...
- Lalithaa Jewellery Mart shares shine on debut, list at 32% premium over IPO priceLalithaa Jewellery Mart Share Price: Lalithaa Jewellery Mart made a remarkable entrance on Monday, entering the stock market with a strong ...
- Rs 21,000 crore IPO rush in August highest in one year. Will September break all records?In August, India's IPO market witnessed a remarkable recovery, becoming the most active month in nearly a year. Over twenty companies succe...
- IPO rush continues: 10 issues to raise over Rs 3,500 crore this weekThis week sees the launch of six mainboard IPOs and four from the SME sector, with total fundraising expected to surpass Rs 3,500 crore. Am...
- Can Symbiotec Pharmalab IPO deliver long-term growth for high-risk investors?Symbiotec Pharmalab plans a ₹150 crore IPO to repay debt and expand operations. The company holds a global leadership position in corticost...
- Rs 3,300 crore IPO week: Symbiotec, Skyways Air to lead 10-offer rush for investorsIndia's IPO market is set for a busy week, with 10 companies, including Symbiotec Pharmalab, Skyways Air Services, Hy-Tech Engineers and Lu...
- 20 IPOs on investors' radar next week. GMPs indicate up to 90% returnsA total of 20 IPOs are on investors’ radar next week, including fresh issues and upcoming listings across the mainboard and SME segments. S...
- Symbiotec Pharmalab gets Rs 526 crore anchor backing ahead of IPO; Citi Group, Singularity among investorsSymbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical ...
- Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 1...
Load More
